MedPath

GD-DICLOFENAC/MISOPROSTOL 75

GD-DICLOFENAC/MISOPROSTOL 75

Approved
DIN Number

02341697

Drug Class

Human

Market Date

Jul 22, 2014

Company
HC

genmed a division of pfizer canada ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02341697
AIG Number0222885004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AB55 DICLOFENAC, COMBINATIONS
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (2)

DICLOFENAC SODIUMActive
Strength: 75 MG
Monograph: DICLOFENAC SODIUM
MISOPROSTOLActive
Strength: 200 MCG
Monograph: MISOPROSTOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.